Skip to main content

Table 1 Additional variables calculated concerning the period of obtaining ethics approval and the screening and trial period

From: Central coordination as an alternative for local coordination in a multicenter randomized controlled trial: the FAITH trial experience

Variable

Calculation

Time necessary for ethics/IRB approval (days)

a - b

Time between ethics/IRB approval and start trial (days)

c - a

Screening period (days)

f - e

Enrolment/trial period (days)

d - c

Total number of patients in screening period (n per month)

g/(f - e)

Number of eligible patients in screening period (n per month)

h/(f - e)

Proportion eligible patients of total in screening period (%)

(h/g) * 100

Total number of patients per month in trial period (n per month)

(i + j)/(d - c)

Number of inclusions in trial period (n per month)

i/(d - c)

Proportion inclusions of total in trial period (%)

(i/(i + j)) * 100

Proportion patients that were missed for registration in trial period of total (%)

(k/(i + j + k)) * 100

Rate of total number of patients per month in trial period versus screening period

((i + j)/(d - c))/(g/(f - e))

Rate of number of inclusions/eligible patients per month in trial period versus screening period

(i/(d - c))/(h/(f - e))

Rate of percentage inclusions/eligible patients per month in trial period versus screening period

((i/(i + j) * 100)/((h/g) * 100)

  1. a, ethics/IRB approval date; b, ethics/IRB submission date; c, trial start date; d, trial stop date; e, screening start date; f, screening stop date; g, total number of patients screened; h, number of eligible patients screened; i, number of inclusions; j, number of excluded or missed patients that were registered; k, number of patients that were missed for registration.